News
-
J&J sees 2012 dip
Wednesday | Apr 18 2012JOHNSON & Johnson sales decreased 0.2% year-on-year in the first quarter of 2012 to US$16.1 billion,.
-
Needle-free is a winner
Wednesday | Apr 18 2012VAXXAS’ new needle-free vaccine delivery system, Nanopatch, has been awarded the Best Venture Capital Investment at.
-
Abbott’s biomarkers
Wednesday | Apr 18 2012ABBOTT has secured an exclusive license for several novel biomarkers from Stanford University.
-
Repeat offenders slammed
Wednesday | Apr 18 2012THE Pharmacy Board of Australia has slammed actions by pharmacists to encourage patients to seek prescriber.
-
Addiction risks
Wednesday | Apr 18 2012OPIOIDS have the highest risk of causing mortality when looking at drugs of addiction, including alcohol.
-
Australians and the flu
Wednesday | Apr 18 2012MANY Australians avoid flu vaccinations and instead rely on garlic, hand sanitiser and chicken soup to.
-
Unhealthy athletics
Wednesday | Apr 18 2012THE tide of unhealthy advertising in the sport world may be turning, with a University of.
-
Reducing risks
Wednesday | Apr 18 2012THE Government is hoping to improve safety at suicide hotspots, by inviting organisations to apply for.
-
Aussie clinical trials growth
Wednesday | Apr 18 2012THE number of clinical trials undertaken in Australia has grown for the first time in four.
-
Pharmacy FAQs
Wednesday | Apr 18 2012THE Pharmacy Board of Australia has posted answers to frequently asked questions regarding continuing professional development.